Switzerland· 63132003
Ultibro Breezhaler 110/50, Hartkapseln mit Pulver zur Inhalation
A indacaterol und glycopyrronium bromid product containing indacaterolum, glycopyrronium, registered in Switzerland by Novartis Pharma Schweiz AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Indacaterol und glycopyrronium bromid is registered in 11 of 19 countries.
Countries holding a registration under ATC R03AL04 (indacaterol und glycopyrronium bromid), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Indacaterol und glycopyrronium bromid · ATC R03AL04
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- indacaterolum, glycopyrronium
- Manufacturer
- Novartis Pharma Schweiz AG
- Country
- Switzerland (CH)
- ATC code
- R03AL04
- ATC class
- Indacaterol und Glycopyrronium bromid
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768063132003190 StkCHF 164.9
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indacaterol und glycopyrronium bromid in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainPOUPOX 85 MICROGRAMOS/43 MOCROGRAMOS POLVO PARA INHALACION (CAPSULA DURA)Laboratorios Liconsa S.A.
- NetherlandsDILABRO 85 microgram/43 microgram inhalatiepoeder in harde capsulesS.F Group S.r.l.
- IcelandPlungymedMedical Valley Invest AB
- PolandAmidil Combo AmiHalerZakłady Farmaceutyczne POLPHARMA S.A.
- CanadaULTIBRO BREEZHALERNOVARTIS PHARMACEUTICALS CANADA INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9603a487-cd0f-4a8f-90fb-f9eacd3a3bb3 GET /v1/drugs/9603a487-cd0f-4a8f-90fb-f9eacd3a3bb3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "indacaterolum 110 mcg + glycopyrronium 50 mcg",
"valid_from": "2018-11-01",
"limitations": null,
"galenic_form": "Inh Kaps 110mcg/50mcg",
"therapeutic_area": null,
"sl_inclusion_date": "2018-11-01",
"self_retention_pct": 10
}See everything about indacaterol und glycopyrronium bromid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.